# Catherine Thiéblemont

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/catherine-thieblemont/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,054 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 102 |
| i10-index | 390 |
| Last Known Institution | Université Paris Cité |
| OpenAlex ID | https://openalex.org/A5033073385 |
| ORCID iD | https://orcid.org/0000-0002-9941-2448 |
| Works | 884 |

## Researcher papers

- [Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial](https://scholariq.org/papers/epcoritamab-a-novel-subcutaneous-cd3xcd20-bispecific-t-cell-engaging-antibody-in/)
- [Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations](https://scholariq.org/papers/immune-effector-cell-associated-hematotoxicity-eha-ebmt-consensus-grading-and/)
- [Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma](https://scholariq.org/papers/prophylactic-corticosteroid-use-in-patients-receiving-axicabtagene-ciloleucel/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [CNS Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/cns-lymphoma-diagnosis-and-treatment/)
- [Viral-associated cancers and disorders](https://scholariq.org/topics/viral-associated-cancers-and-disorders-2/)

## Researcher university

- [Université Paris Cité](https://scholariq.org/institutions/universite-paris-cite/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.